Page last updated: 2024-11-01

omeprazole and Pheochromocytoma, Extra-Adrenal

omeprazole has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vieira, AE1
Mello, MP1
Elias, LL1
Lau, IF1
Maciel, LM1
Moreira, AC1
Castro, M1

Other Studies

1 other study available for omeprazole and Pheochromocytoma, Extra-Adrenal

ArticleYear
Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2002, Volume: 34, Issue:4

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Anti-Ulcer Agents; Calcitonin; Carcinoma, Medullary; Chi

2002